NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Multi-Laboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements
Published
Author(s)
Hua-Jun He, Erica V. Stein, Yves Konigshofer, Thomas Forbes, Farol L. Tomson, Russell Garlick, Emiko Yamada, Tony Godfrey, Toshiya Abe, Koji Tamura, Michael Borges, Michael Goggins, Sandra Elmore, Margaret L. Gulley, Jessica L. Larson, Lando Ringel, Brian C. Haynes, Corinne Camalier, Chris Karlovich, Biswajit Das, P. M. Williams, Aaron Garnett, Anders Stahlberg, Stefan Filges, Lynn Sorbara, Mathew R. Young, Sudhir Srivastava, Kenneth D. Cole
Abstract
We conducted a multi-laboratory assessment to determine the suitability of a new commercially- available reference material with 40 cancer variants in a background of wild-type DNA at four different variant allele fractions (VAF): 2%, 0.5%, 0.125%, and 0 %. The variants include single nucleotides, insertions, deletions, and two structural variations selected both for their clinical importance, and to challenge the performance of next generation sequencing (NGS) methods. Fragmented DNA was formulated to simulate the size distribution of circulating wild- type and tumor DNA (ctDNA) in a synthetic plasma matrix. DNA was extracted from these samples and characterized with different methods and multiple laboratories. The various extraction methods had differences in yield, and automated methods resulted in lower yields. Digital PCR assays were used to measure VAFs to compare results from different NGS methods. Comparable VAFs were observed across the different NGS methods (including targeted amplicon or hybrid capture with and without molecular barcodes). This multi-laboratory assessment demonstrates that the new reference material is an appropriate tool for comparing the performance of different approaches and ensuring the reproducibility of ctDNA measurements including pre-analytical, analytical, and post-analytical data analysis steps.
He, H.
, Stein, E.
, Konigshofer, Y.
, Forbes, T.
, Tomson, F.
, Garlick, R.
, Yamada, E.
, Godfrey, T.
, Abe, T.
, Tamura, K.
, Borges, M.
, Goggins, M.
, Elmore, S.
, Gulley, M.
, Larson, J.
, Ringel, L.
, Haynes, B.
, Camalier, C.
, Karlovich, C.
, Das, B.
, Williams, P.
, Garnett, A.
, Stahlberg, A.
, Filges, S.
, Sorbara, L.
, Young, M.
, Srivastava, S.
and Cole, K.
(2019),
Multi-Laboratory Assessment of a New Reference Material for Quality Assurance of Cell-Free Tumor DNA Measurements, Journal of Molecular Diagnostics, [online], https://doi.org/10.1016/j.jmoldx.2019.03.006, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=926883
(Accessed October 28, 2025)